BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30778614)

  • 1. Molecular modeling of LDLR aids interpretation of genomic variants.
    Klee EW; Zimmermann MT
    J Mol Med (Berl); 2019 Apr; 97(4):533-540. PubMed ID: 30778614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations.
    Guo J; Gao Y; Li X; He Y; Zheng X; Bi J; Hou L; Sa Y; Zhang M; Yin H; Jiang L
    Atherosclerosis; 2019 Feb; 281():1-8. PubMed ID: 30583242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
    Alnouri F; Athar M; Al-Allaf FA; Abduljaleel Z; Taher MM; Bouazzaoui A; Al Ammari D; Karrar H; Albabtain M
    Atherosclerosis; 2018 Oct; 277():425-433. PubMed ID: 30270081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary spectrum of genetic variants in familial hypercholesterolemia in Argentina.
    Bañares VG; Corral P; Medeiros AM; Araujo MB; Lozada A; Bustamante J; Cerretini R; López G; Bourbon M; Schreier LE
    J Clin Lipidol; 2017; 11(2):524-531. PubMed ID: 28502510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
    Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
    Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.
    Reeskamp LF; Hartgers ML; Peter J; Dallinga-Thie GM; Zuurbier L; Defesche JC; Grefhorst A; Hovingh GK
    Circ Genom Precis Med; 2018 Dec; 11(12):e002385. PubMed ID: 30562117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a recurrent frameshift mutation at the LDLR exon 14 (c.2027delG, p.(G676Afs*33)) causing familial hypercholesterolemia in Saudi Arab homozygous children.
    Al-Allaf FA; Alashwal A; Abduljaleel Z; Taher MM; Siddiqui SS; Bouazzaoui A; Abalkhail H; Aun R; Al-Allaf AF; AbuMansour I; Azhar Z; Ba-Hammam FA; Khan W; Athar M
    Genomics; 2016 Jan; 107(1):24-32. PubMed ID: 26688439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient.
    Al-Allaf FA; Alashwal A; Abduljaleel Z; Taher MM; Bouazzaoui A; Abalkhail H; Al-Allaf AF; Athar M
    Acta Biochim Pol; 2017; 64(1):75-79. PubMed ID: 27878139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel LDLR variants in patients with familial hypercholesterolemia: in silico analysis as a tool to predict pathogenic variants in children and their families.
    Mollaki V; Progias P; Drogari E
    Ann Hum Genet; 2013 Sep; 77(5):426-34. PubMed ID: 23815734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia.
    Rodríguez-Jiménez C; Pernía O; Mostaza J; Rodríguez-Antolín C; de Dios García-Díaz J; Alonso-Cerezo C; García-Polo I; Blanco A; Lahoz C; Arrieta F; Beltrán L; Díaz de Bustamante A; Garzón-Lorenzo L; Álvarez-Sala LA; Asenjo Á; Ibáñez de Cáceres I; Rodríguez-Nóvoa S
    Hum Mutat; 2019 Aug; 40(8):1181-1190. PubMed ID: 31106925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Function Relationships of LDL Receptor Missense Mutations Using Homology Modeling.
    Porntadavity S; Jeenduang N
    Protein J; 2019 Aug; 38(4):447-462. PubMed ID: 31401775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants.
    Benito-Vicente A; Uribe KB; Jebari S; Galicia-Garcia U; Ostolaza H; Martin C
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition.
    Benito-Vicente A; Uribe KB; Siddiqi H; Jebari S; Galicia-Garcia U; Larrea-Sebal A; Cenarro A; Stef M; Ostolaza H; Civeira F; Palacios L; Martin C
    PLoS One; 2018; 13(10):e0204771. PubMed ID: 30332439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
    Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
    Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
    Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
    Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of the benign c.2579C>T (p.A860V) variant of the LDLR gene in a pedigree-based genetic analysis of familial hypercholesterolemia.
    Hori M; Miyauchi E; Son C; Harada-Shiba M
    J Clin Lipidol; 2019; 13(2):335-339. PubMed ID: 30745271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report.
    Paththinige CS; Rajapakse JRDK; Constantine GR; Sem KP; Singaraja RR; Jayasekara RW; Dissanayake VHW
    Lipids Health Dis; 2018 May; 17(1):100. PubMed ID: 29720182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of D151Y and M391T mutations in the LDL receptor.
    Jeenduang N; Promptmas C; Pongrapeeporn KS; Porntadavity S
    Biochem Biophys Res Commun; 2008 Dec; 377(2):355-360. PubMed ID: 18929537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of variations and identifying genomic breakpoints for large deletions in the LDLR by Ion Torrent semiconductor sequencing.
    Faiz F; Allcock RJ; Hooper AJ; van Bockxmeer FM
    Atherosclerosis; 2013 Oct; 230(2):249-55. PubMed ID: 24075752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.